Covid booster sparks world's deadliest virus inside man's body
THE DETAILS …
Researchers in India have raised alarming concerns that dormant viruses lying inactive within the human body could be reactivated by COVID-19 vaccines, potentially leading to severe health consequences, including cancer. This theory, explored in a study published in the International Journal of Molecular Sciences, suggests that mRNA vaccines, such as those developed by Pfizer and Moderna, may interfere with critical immune system proteins known as toll-like receptors (TLRs). These receptors play a vital role in distinguishing between the body’s own cells and foreign invaders, like viruses. When their function is impaired, latent viruses—such as herpesviruses, hepatitis viruses, and human papillomavirus (HPV)—could “reawaken,” triggering a cascade of health issues, including chronic inflammation, autoimmune disorders, and tumor development.
The study highlights how mRNA vaccines, designed to instruct cells to produce the SARS-CoV-2 spike protein to provoke an immune response, may inadvertently disrupt the immune system’s delicate balance. Specifically, the spike protein is believed to impair TLR4, a receptor crucial for suppressing the reactivation of dormant viruses. This disruption could allow viruses like Epstein-Barr virus (EBV), which is linked to cancers such as lymphoma, or HPV, associated with cervical cancer, to become active again. The researchers point to rising global cancer rates, particularly among younger adults, as a potential indicator of this phenomenon, with US data showing a 12 percent increase in colon cancer and a 10 percent rise in breast cancer among those under 50 between the early 2000s and 2020. While the study does not claim that mRNA vaccines directly cause cancer, it suggests they could act as a “tipping point” for individuals already harboring latent viruses, especially in regions like India, where hepatitis B and HPV infections are prevalent.
(see more below)
The implications of these findings are profound, particularly for countries with high rates of latent viral infections and ongoing mass vaccination campaigns. In India, where hepatitis B affects up to 40 million people and HPV is a leading cause of cervical cancer, the potential reactivation of these viruses could strain an already burdened healthcare system. The researchers call for urgent further investigation into the long-term effects of mRNA vaccines on immune function, emphasizing the need for enhanced cancer screening and monitoring of vaccinated populations. They also advocate for a reevaluation of vaccine safety protocols to ensure that the benefits of immunization against COVID-19 are not outweighed by unintended consequences, such as the reactivation of dormant viruses and subsequent health risks.